In a new study published in Health Affairs, researchers at Beth Israel Deaconess Medical Center (BIDMC) and the Harvard T.H. Chan School of Public Health examines the association between community-level factors and COVID-19 case rates across 351 cities and towns in Massachusetts between January 1 and May 6, 2020.
Researcher-clinicians from Beth Israel Deaconess Medical Center (BIDMC) and Lahey Hospital and Medical Center, both part of Beth Israel Lahey Health, have collaborated to develop an online assessment tool to help patients and providers make more informed decisions about choosing and using a mental health app.
Before lathering on the sunscreen and heading outdoors, it's important to know the signs of heat-related injuries and how to stay cool when the temperatures soar.
The July 2020 Edition of Beth Israel Deaconess Medical Center’s (BIDMC) Research & Health News Digest.
A leading COVID-19 vaccine candidate developed at Beth Israel Deaconess Medical Center creates the groundwork for a newly launched COVID-19 vaccine clinical trial
"Because it affects them in their childbearing years, women need to know when it is safe to get pregnant," says Dr. Jacqueline Wolf, a national expert on IBD and pregnancy and a physician in the Division of Gastroenterology, Hepatology and Nutrition at Beth Israel Deaconess Medical Center, shares her expertise on Crohn's disease and pregnancy.
While screening guidelines for hepatitis C previously targeted baby boomers, experts say more universal testing guidelines should be followed for early detection and better outcomes.
Researchers from BIDMC report on the decline of emergent medical, surgical and obstetric hospitalizations at the medical center during the six-week period following the week of the declaration of the COVID-19 public health emergency in Boston in mid-March 2020.
In a paper published in Cancer and Metastasis Reviews, a team of researchers from Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital propose that controlling the local and systemic inflammatory response in COVID-19 may be as important as anti-viral and other therapies.
Early in the COVID-19 pandemic, widespread cancellations of electively-scheduled or “non-emergency” operations were implemented to free up hospital beds and conserve protective equipment for health care workers. For some conditions, including cancer, timely surgery is critical for patients’ survival. In a new study published in the Journal of Gastrointestinal Surgery, a team of investigators at Beth Israel Deaconess Medical Center (BIDMC) examined the effects of delaying surgery for gastrointestinal cancers.
The findings of a nationwide survey assessing the effects of the COVID-19 pandemic on the emotional wellbeing of U.S. adults show 90 percent of survey respondents reported experiencing emotional distress related to the pandemic.
A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.
A new Viewpoint article published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory distress syndrome (ARDS) with mechanical ventilation.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) and colleagues reported today in Science two studies of laboratory monkeys that suggest antibodies produced during recovery from COVID-19 provide immunity from the virus, whether triggered by infection or vaccine.
A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.
BIDMC dietitian Elisabeth Moore, RD, shares tips for grocery shopping and suggests heart-healthy pantry items to stock up on during the COVID-19 pandemic.
BIDMC's Chief of Podiatric Surgery John Giurini, DPM, shares some insight on avoiding common injuries and knowing when it's time to see a podiatrist.
Elisabeth Moore, RD, a dietitian at Beth Israel Deaconess Medical Center, offers advice to help us make healthy snack choices during these trying times.
BIDMC’s Blair Wylie, MD, MPH, Director of Maternal-Fetal Medicine, and Chloe Zera, MD, MPH, Director of Obstetric Population Health, provide some information and advice for expecting parents.
Barbara A. Masser, MD, Medical Director at BIDMC urgent care centers in Chelsea and Chestnut Hill, offers advice to help you make the right decision when your care can't wait.
A clinical trial conducted by a multi-disciplinary team from Beth Israel Deaconess Medical Center has identified four novel prototypes of 3D-printed swabs that can be used for COVID-19 testing.
Physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a potential treatment of patients with COVID-19. Part of a multi-site investigation, the trial is evaluating the safety and efficacy of sarilumab, a biologic medication already approved for adults with moderately to severely active rheumatoid arthritis, for the treatment of COVID-19.
A team of physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with ARDS. The newly launched trial follows a special report the team published in the Journal of Trauma and Acute Care Surgery that suggested the use of a drug called tPA could reduce deaths among patients with ARDS as a complication of COVID-19.
As the numbers of patients with confirmed and suspected COVID-19 in the United States continue to rise exponentially, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC), part of Beth Israel Lahey Health, launched a collaborative and open-source effort to address the shortage of swabs that is hampering the nation’s ability to test for and track the spread of the virus. The team’s mission is to catalyze the development and clinical validation of novel designs for swabs for COVID-19 testing that can be manufactured quickly and in large numbers.
Physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused by the novel coronavirus. Two trials, led by infectious disease specialist Kathryn Stephenson, MD, MPH, will test the antiviral drug remdesivir for safety and efficacy against the respiratory infection that has sickened more than 300,000 and killed more than 15,000 around the world to date.
BIDMC geriatrician Medha Munshi, MD, breaks down the difference between a geriatrician and a PCP.
In a new study published today in JAMA, a team of researchers at Beth Israel Deaconess Medical Center (BIDMC) evaluated how health outcomes for low-income older adults who are dually enrolled in both Medicare and Medicaid have changed since the early 2000s.
BIDMC clinician-researchers provide new evidence about the optimal way to treat patients who carry BRCA mutations who have been diagnosed with breast cancer.
Rich Schwartzstein, MD, Director of the Carl J. Shapiro Institute for Education and Research at BIDMC, available for interview to discuss his perspective on the MCAT and its use in medical school admissions.
A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right